HUTCHMED (China) Ltd financial data

Symbol
HCM on Nasdaq, HMDCF on OTC
Industry
Pharmaceutical Preparations
Location
48 Th Floor, Cheung Kong Center, 2 Queen's Road Central, Hong Kong, Hong Kong
State of incorporation
Cayman Islands
Former names
Hutchison China MediTech Ltd (to 4/29/2021)
Latest financial report
20-F - Q4 2023 - Feb 28, 2024

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 871M shares +0.75%
Common Stock, Value, Issued 87.1M USD +0.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 204M USD -8.54%
Cash, Cash Equivalents, and Short-term Investments 802M USD -6.27%
Accounts Receivable, after Allowance for Credit Loss, Current 157M USD +21.4%
Inventory, Net 46.4M USD -13.8%
Assets, Current 1.05B USD -3.87%
Deferred Income Tax Assets, Net 15.5M USD +0.59%
Property, Plant and Equipment, Net 94.8M USD -2.08%
Operating Lease, Right-of-Use Asset 6.39M USD -30.5%
Intangible Assets, Net (Excluding Goodwill) 21K USD -75.3%
Goodwill 3.02M USD -1.6%
Other Assets, Noncurrent 37.3M USD -5.75%
Assets 1.26B USD -2.82%
Accounts Payable, Current 43.4M USD -20.5%
Employee-related Liabilities, Current 26.2M USD -3.59%
Contract with Customer, Liability, Current 48.2M USD -7.87%
Liabilities, Current 373M USD +9.51%
Contract with Customer, Liability, Noncurrent 97.2M USD
Deferred Income Tax Liabilities, Net 1.48M USD -45.2%
Operating Lease, Liability, Noncurrent 2.86M USD -45%
Other Liabilities, Noncurrent 19.3M USD +0.06%
Liabilities 509M USD +2.29%
Accumulated Other Comprehensive Income (Loss), Net of Tax -9.53M USD -22.2%
Retained Earnings (Accumulated Deficit) -845M USD -5.23%
Stockholders' Equity Attributable to Parent 740M USD -5.37%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 752M USD -6%
Liabilities and Equity 1.26B USD -2.82%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 1.5B shares 0%
Common Stock, Shares, Issued 871M shares +0.6%
Common Stock, Par or Stated Value Per Share 0.1 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 204M USD -8.54%
Deferred Tax Assets, Valuation Allowance 284M USD +7.14%
Deferred Tax Assets, Gross 299M USD +6.78%
Operating Lease, Liability 6.79M USD -23.8%
Lessee, Operating Lease, Liability, to be Paid 6.98M USD -24.7%
Property, Plant and Equipment, Gross 146M USD +29.7%
Operating Lease, Liability, Current 3.93M USD +5.91%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.19M USD -51.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 4.04M USD +3.43%
Operating Lease, Weighted Average Discount Rate, Percent 0.03 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 188K USD -47.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 919K USD -21.9%
Deferred Tax Assets, Operating Loss Carryforwards 284M USD +7.37%
Lessee, Operating Lease, Liability, to be Paid, Year Four 698K USD -23.4%
Deferred Tax Assets, Net of Valuation Allowance 15.5M USD +0.59%